Long-term Outcomes in Use of Opioids, Nonpharmacologic Pain Interventions, and Total Costs of Spinal Cord Stimulators Compared With Conventional Medical Therapy for Chronic Pain

Authors:

Abstract
Spinal cord stimulators (SCSs) are neuromodulation devices implanted in the epidural space with the goal of treating chronic pain that fails to respond to conventional treatment. SCSs have been increasingly used in recent years1,2; approximately 50 000 are implanted annually in the US3 at a cost of approximately $3.5 billion.4 Some have advocated for greater use of SCSs to reduce risks of medications, including opioids and gabapentinoids.5

This publication has 34 references indexed in Scilit: